Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR

Pharmaceutical Research

Volumn 23, Issue 11, 2006, Pages 2566-2574

  Pongpeerapat, Adchara ^a   Higashi, Kenjirou ^a   Tozuka, Yuichi ^a   Moribe, Kunikazu ^a   Yamamoto, Keiji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Grinding; Nanoparticle; Polyvinylpyrrolidone; Sodium dodecyl sulfate; Solid state NMR

Indexed keywords

DODECYL SULFATE SODIUM; POVIDONE IODINE; PROBUCOL;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG SYNTHESIS; MASS SPECTROMETRY; MOLECULAR INTERACTION; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE; POLARIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; X RAY DIFFRACTION;

MAGNETIC RESONANCE SPECTROSCOPY; NANOPARTICLES; PARTICLE SIZE; POVIDONE; PROBUCOL; SODIUM DODECYL SULFATE; X-RAY DIFFRACTION;

EID: 33750614933     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9089-z     Document Type: Article

References (25)

1. N. Kondo, T. Iwao, H. Masuda, K. Yamanouchi, Y. Ishihara, N. Yamada, T. Haga, Y. Ogawa, and K. Yokoyama. Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. Chem. Pharm. Bull. 41:737-740 (1993).
2. M. Sugimoto, T. Okagaki, S. Narisawa, Y. Koida, and K. Nakajima. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm. 160:11-19 (1998).
3. H. Suzuki, M. Ogawa, K. Hironaka, K. Ito, and H. Sunada. A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability. Drug Dev. Ind. Pharm. 27:951-958 (2001).
4. H. G. Brittain. Effect of mechanical processing on phase composition. J. Pharm. Sci. 91:1573-1580 (2002).
5. H. Sekizaki, K. Danjo, H. Eguchi, Y. Yonezawa, H. Sunada, and A. Otsuka. Solid-state interaction of ibuprofen with polyvinylpyrrolidone. Chem. Pharm. Bull. 43:988-993 (1995).
6. N. Yagi, Y. Terashima, H. Kenmotsu, H. Sekikawa, and M. Takada. Dissolution behavior of probucol from solid dispersion systems of probucol-polyvinylpyrrolidone. Chem. Pharm. Bull. 44:241-244 (1996).
7. V. Tantishaiyakul, N. Kaewnopparat, and S. Ingkatawornwong. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 181:143-151 (1999).
8. E. Broman, C. Khoo, and L. S. Taylor. A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water-soluble drug. Int. J. Pharm. 222:139-151 (2001).
9. E. Merisko-Liversidge, P. Sarpotdar, J. Bruno, S. Hajj, L. Wei, N. Peltier, J. Rake, J. M. Shaw, S. Pugh, L. Polin, J. Jones, T. Corbett, E. Cooper, and G. G. Liversidge. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drug. Pharm. Res. 13:272-278 (1996).
10. M. Aldén, J. Tegenfeldt, and E. Sjökvist. Structure of solid dispersion in the system polyethylene glycol-griseofulvin with additions of sodium dodecyl sulphate. Int. J. Pharm. 83:47-52 (1992).
11. 13C NMR and ESR. Colloid Polym. Sci. 276:1-10 (1998).
12. R. Nörenberg, J. Klingler, and D. Horn. Study of the interactions between poly(vinyl pyrrolidone) and sodium dodecyl sulfate by fluorescence correlation spectroscopy. Angew. Chem. Int. Ed. 38:1626-1629 (1999).
13. D. Sukul, S. K. Pal, D. Mandal, S. Sen, and K. Bhattacharyya. Excited state proton transfer as a probe for polymer-surfactant interaction. J. Phys. Chem. B. 104:6128-6132 (2000).
14. P. A. Tishmack, D. E. Bugay, and S. R. Byrn. Solid-state nuclear magnetic resonance spectroscopy - pharmaceutical application. J. Pharm. Sci. 92:441-474 (2003).
15. R. Lefort, A. Gusseme De, J. F. Willart, F. Danède, and M. Descamps. Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: an application to ball-milling of trehalose. Int. J. Pharm. 280:209-219 (2004).
16. Y. Tozuka, A. Ito, H. Seki, T. Oguchi, and K. Yamamoto. Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy. Chem. Pharm. Bull. 50:1128-1130 (2002).
17. P. J. Saindon, N. S. Cauchon, P. A. Sutton, C. J. Chang, G. E. Peck, and S. R. Byrn. Solid-state nuclear magnetic resonance (NMR) spectra of pharmaceutical dosage forms. Pharm. Res. 10:197-203 (1993).
18. T. Watanabe, S. Hasegawa, N. Wakiyama, A. Kusai, and M. Senna. Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion. Int. J. Pharm. 250:283-286 (2003).
19. K. Itoh, A. Pongpeerapat, Y. Tozuka, T. Oguchi, and K. Yamamoto. Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS. Chem. Pharm. Bull. 51:171-174 (2003).
20. A. Pongpeerapat, K. Itoh, Y. Tozuka, K. Moribe, T. Oguchi, and K. Yamamoto. Formation and stability of drug/PVP/SDS ternary ground mixture. J. Drug Del. Sci. Tech. 14:441-447 (2004).
21. K. Moribe, A. Pongpeerapat, Y. Tozuka, and K. Yamamoto. Drug nanoparticle formation from Drug/HPMC/SDS ternary ground mixtures. Pharmazie 61:97-101 (2006).
22. J. J. Gerber, M. R. Caira, and A. P. Lötter. Structures of two conformational polymorphs of the cholesterol-lowering drug probucol. J. Cryst. Spectrosc. 23:863-869 (1993).
23. P. Roscigno, F. Asaro, G. Pellizer, O. Ortana, and L. Paduano. Complex formation between poly(vinylpyrrolidone) and sodium decyl sulfate studied through NMR. Langmiur 19:9638-9644 (2003).
24. S. W. Kuo and F. C. Chang. Studies of miscibility behavior and hydrogen bonding in blends of poly (vinylphenol) and poly (vinylpyrrolidone). Macromolecules 34:5224-5228 (2001).
25. A. R. Sheth, J. W. Lubach, E. J. Munson, F. X. Muller, and D. J. W. Grant. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. J. Am. Chem. Soc. 127:6641-6651 (2005).